Core Viewpoint - The company announced that its stock price experienced an abnormal fluctuation, with a cumulative increase of 30% over three consecutive trading days (August 8, August 11, and August 12, 2025) [1] Company Overview - The company specializes in the research, development, production, and sales of medical devices related to pelvic floor and obstetric rehabilitation [1] - Its main product offerings include pelvic floor and obstetric rehabilitation, reproductive rehabilitation, anti-aging, sports rehabilitation, consumables, and information technology products [1] Financial Impact - Currently, the revenue contribution from sports rehabilitation products is relatively small and has not significantly impacted the company's overall performance [1]
麦澜德:目前运动康复产品收入占比较小 暂未对公司业绩产生重大影响